DESolve Novolimus Eluting Coronary BRS

Summary

Five year results of a fully bioresorbable novolimus-eluting coronary scaffold system: what began as a question of looking into the short-term safety and efficacy of an innovative BRS is now playing out in the long-term with equally surprising results. For the first time, a BRS has been shown to degrade within 6-9 months with absorption within one year. With S. Verheye we learn about the implications of this device and explore the current data including TLR, mortality and scaffold thrombosis. Watch here…